Biotech Firm Slashes 75% of Staff After FDA Rejects Drug for

Biotech Firm Slashes 75% of Staff After FDA Rejects Drug for Rare Lung Cancer

In rejecting Spectrum Pharmaceuticals drug poziotinib, the FDA said the biotech needs to generate more data from another clinical trial. Instead, Spectrum is turning the company’s focus to commercializing its recently approved product for treating a common cancer complication.

Related Keywords

Coherus Biosciences , Amgen , Pfizer , A Spectrum Pharmaceuticals , Spectrum Pharmaceuticals , Boston Based Spectrum , Spectrum President , Weight Loss , Obesity , Verweight , Diabetes , Massachusetts , Medical Devices , Startups , Healthcare Innovation , Medcity News , San Francisco , Life Sciences , Accelerator , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Dc , Healthcare It , Washington , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery , Cambridge , Dealflow , Hospitals , Wellpoint , Ealthways , Ealth And Wellness , Mployee Wellness Programs , Investing , Wellness , Medtronic , Hanghai Innovation Center , China , R D , Mdt , Minneapolis , Minnesota , Publics , Twin Cities , Ulcerative Colitis , Abbott Labs , Humira , Doctors , Pharmaceuticals , Skin Disorders , D Anderson Cancer Center , Cancer , Texas , Renal Denervation , St Jude Medical , Stj , Emr , Hr , Electronic Health Records , Electronic Medical Records , Certified Emr , Ehr , Advanced Cellular Technology , Amyotrophic Lateral Sclerosis , Embryonic Stem Cells , Geron Corporation , Lou Gehrigs Disease , Macular Degeneration , Regenerative Medicine , Spinal Cord Damage , Value Based Healthcare System , Obamacare , Ee For Service Model , California , Cleveland , Health Insurance , Insurance , Ohio , Pennsylvania , Politics , Cancer Treatment Options Library , Aetna , Pet , Aet , Health It , Phi , Philadelphia , Biopharma Nl , Boston , Dancer , Clinical Trials , Fda , Non Small Cell Lung Cancer , ,

© 2025 Vimarsana